Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;45(4):957-965.
doi: 10.1007/s11596-025-00086-4. Epub 2025 Aug 8.

Electroacupuncture Improves Gastrointestinal Motility in Rats with Functional Dyspepsia via the GDNF/GFRα1/PI3K/Akt Signaling Pathway

Affiliations

Electroacupuncture Improves Gastrointestinal Motility in Rats with Functional Dyspepsia via the GDNF/GFRα1/PI3K/Akt Signaling Pathway

Li Zhou et al. Curr Med Sci. 2025 Aug.

Abstract

Objective: Abnormal gastrointestinal motility plays a crucial role in the pathogenesis of functional dyspepsia (FD). Although electroacupuncture (EA) has demonstrated efficacy in FD treatment, its precise mechanism remains unclear. This study aimed to elucidate the specific mechanism through which EA improves gastrointestinal motility in FD.

Methods: Physiological indices, including body weight, food intake, gastrointestinal motility, and gastrointestinal morphology, were utilized to assess the FD model in rats. EA interventions were applied at meridian points, as well as non-meridian points and non-acupoints, in FD model rats. The effects of EA at zusanli (ST36) and taichong (LR3) on gastrointestinal motility in FD model rats were elucidated using gastrointestinal motility test indices. Techniques such as Western blotting, quantitative real-time PCR, and immunofluorescence were employed to determine the specific mechanisms by which EA improved gastrointestinal motility in FD model rats.

Results: Multifactorial stress intervention could be used to effectively establish an FD rat model. EA at ST36 and LR3 significantly improved gastrointestinal motility. Furthermore, EA at ST36 and LR3 upregulated the protein expression of glial cell line-derived neurotrophic factor (GDNF), GDNF family receptor alpha 1 (GFRα1), phosphatidylinositol 3-kinase (PI3K), and protein kinase B (Akt), along with their mRNA expression levels and the number of enteric glial cells (EGCs).

Conclusions: EA was capable of increasing the number of EGCs by activating the GDNF/GFRα1/PI3K/Akt signaling pathway, thereby improving gastrointestinal motility in FD.

Keywords: Electroacupuncture; Enteric glial cell; Enteric nervous system; Functional dyspepsia; Gastrointestinal motility.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of Interest: The authors declare that they have no competing interests. Ethics Approval and Consent to Participate: All procedures were conducted in accordance with the relevant guidelines, and the experimental protocols were approved by the Ethics Committee of Hubei University of Traditional Chinese Medicine (Approval No.: HUCMS 202205002). Consent for Publication: Not applicable.

Similar articles

References

    1. Ford AC, Mahadeva S, Carbone MF, et al. Functional dyspepsia. Lancet. 2020;396(10263):1689–1702. - PubMed
    1. Potter MDE, Talley NJ. Editorial: new insights into the global prevalence of uninvestigated and functional dyspepsia. Aliment Pharmacol Ther. 2020;52(8):1407–1408. - PubMed
    1. Drago L, Meroni G, Pistone D, et al. Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies. J Int Med Res. 2021;49(1):1–13.
    1. Long YQ, Xu WL, Li LX, et al. Characteristics and Risk Factors of Functional Dyspepsia Fulfilling the Rome IV Criteria Overlapping With Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China. J Neurogastroenterol Motil. 2024;30(2):184–193. - PubMed - PMC
    1. Olson CG, Travers P, Lacy BE. Current opinion: functional dyspepsia. Curr Opin Gastroenterol. 2024;40(6):470–476. - PubMed

MeSH terms

Substances

LinkOut - more resources